Primary Site >> Colorectal Cancer

Gene >> SLFN11

Journal: Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):15030-5.
Title: Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents.
Author: Zoppoli, Gabriele|Regairaz, Marie|Leo, Elisabetta|Reinhold, William C|Varma, Sudhir|Ballestrero, Alberto|Doroshow, James H|Pommier, Yves
PMID: 22927417
Journal: Anticancer Drugs. 2014 Nov;25(10):1175-81.
Title: Schlafen-11 sensitizes colorectal carcinoma cells to irinotecan.
Author: Tian, Li|Song, Santai|Liu, Xiaojing|Wang, Yan|Xu, Xiaoguang|Hu, Yi|Xu, Jianming
PMID: 25089570
Journal: BMC Cancer. 2015 Nov 2;15:833.
Title: High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment.
Author: Deng, Yanhong|Cai, Yue|Huang, Yan|Yang, Zihuan|Bai, Yang|Liu, Yanlu|Deng, Xiuping|Wang, Jianping
PMID: 26525741
Journal: Epigenomics. 2017 Jun;9(6):849-862.
Title: Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer.
Author: He, Tao|Zhang, Meiying|Zheng, Ruipan|Zheng, Shufang|Linghu, Enqiang|Herman, James G|Guo, Mingzhou
PMID: 28403629
Journal: Mol Cancer Ther. 2018 Aug;17(8):1694-1704.
Title: Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors.
Author: Marzi, Laetitia|Agama, Keli|Murai, Junko|Difilippantonio, Simone|James, Amy|Peer, Cody J|Figg, William D|Beck, Daniel|Elsayed, Mohamed S A|Cushman, Mark|Pommier, Yves
PMID: 29748210